ABT-869 from ABBEXA LTD

Search, find, compare suppliers for ABT-869 products.

Edit 
Product NameABT-869
DescriptionABT-869 is a small molecule which can act as a VEGFR/PDGFR family inhibitor. It is provided as a powder. This product acts on the following target types: Kinase. This product acts on the following biochemical pathways: AKT, mTOR, Necroptosis. This product may be interest in the following research areas and diseases: Cell death, Angiogenesis, Cancer, Obesity. Please note that our chemical products are for research use only in a laboratory and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. Purity > 98%. MW: 375.4 g/mol
Size5 mg, 25 mg,
Concentrationn/a
Applicationsn/a
Other NamesABT-869, 1-(4-(3-Amino-1H-indazol-4-yl)phenyl)-3-(2-fluoro-5-methylphenyl)urea, Linifanib, 796967-16-3
Gene, Accession, CAS #CAS: 796967-16-3
Catalog #abx182361
Priceplease inquire
Order / More InfoABT-869 from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Products

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.